Prevalence and clinical outcomes of triglyceride deposit cardiomyovasculopathy among haemodialysis patients | Heart

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BCS

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

PDF +
Supplementary
Material

XML

Special populations

Original research

Prevalence and clinical outcomes of triglyceride deposit cardiomyovasculopathy among haemodialysis patients

Online download statistics by month:

Online download statistics by month: September 2020 to March 2024

	Abstract	Full	Pdf
Sep 2020	127	126	4
Oct 2020	516	505	124
Nov 2020	127	122	45
Dec 2020	238	231	54
Jan 2021	164	151	53
Feb 2021	81	77	16
Mar 2021	64	63	21
Apr 2021	81	75	31
May 2021	47	44	32
Jun 2021	62	59	20
Jul 2021	75	75	24
Aug 2021	56	55	14
Sep 2021	49	47	30
Oct 2021	55	53	43
Nov 2021	79	70	44
Dec 2021	57	54	20
Jan 2022	50	45	21
Feb 2022	43	37	18
Mar 2022	55	50	23
Apr 2022	35	33	16
May 2022	65	60	27
Jun 2022	42	35	23
Jul 2022	57	52	21
Aug 2022	53	47	34
Sep 2022	49	39	29
Oct 2022	49	33	30
Nov 2022	24	20	8
Dec 2022	27	24	19
Jan 2023	109	107	29
Feb 2023	200	194	19
Mar 2023	50	50	26
Apr 2023	35	37	17
May 2023	31	31	14
Jun 2023	36	32	11
Jul 2023	36	36	28
Aug 2023	36	35	24
Sep 2023	30	31	11
Oct 2023	39	40	20
Nov 2023	26	25	17
Dec 2023	31	32	11
Jan 2024	142	125	13
Feb 2024	14	13	15
Mar 2024	35	34	17
Total	3277	3104	1116